Navigation Links
Influenza Vaccine FluMist To Be Approved In Younger Children As Well

MedImmune, the company that has successfully sold flu vaccines to healthy adults in the age range of 5 to 49 is now poised on the edge of another victory . The U.S Food and Drug Administration is now about to approve the sale of FluMist targeting children younger than 5 years.

This announcement comes at a time when the company is planning to self itself to UKs AstraZeneca for 15.6 billion dollars. AstraZeneca was behind MedImmune because it did not have its own flu vaccine business. Once the deal closes, MedImmune becomes a wholly owned subsidiary of AstraZeneca.

The vaccine FluMist has had more than its share of hurdles, such as the preliminary safety concerns, being deemed unfit for young kids, and then storage problems as most pharmacies refused the drug as it needed to be stored in the freezer. This was overcome recently by a FDA-approved refrigerator safe version.

The newer version of MedImmune s FluMist appears effective for children younger than 5 years old, although safety data on the influenza vaccine is still under examination.

MedImmune sought FDA approval to market the spray for children ages 1 to 5 without a history of wheezing or asthma.

According to FDA documents, four studies conducted by MedImmune found the drug was effective against Type A and B influenza viruses, including one trial that showed the vaccine was about 90 percent effective.

Reviewers for the FDA also said one company study of the nasal spray vaccine did not signal any widespread safety problems, but results from other studies are still being reviewed. Those findings will be presented to the panel on Wednesday.

Though children who received FluMist experienced more wheezing than those who were given an inactive vaccine, "the difference between treatment groups is quite small," one reviewer said.

Other side effects included pneumonia, among other problems. Previously known side effects with FluMis t include nasal congestion, runny nose, sore throat and cough.

In a separate document, MedImmune claimed the vaccine's safety and efficacy were proven in children 24 to 59 months old and "that the risk-benefit profile for children 12 (to) 23 months of age without a history of wheeze or asthma warrants use of FluMist in this population as well."

It also said it would continue to monitor the drug in younger patients if approved.

FluMist competes with injectable flu vaccines made by GlaxoSmithKline Plc, Sanofi-Aventis' Sanofi Pasteur unit, and Chiron, which was recently acquired by Novartis AG.


'"/>




Related medicine news :

1. Influenza drug delayed
2. Chances are high for Avian Influenza virus altering its form
3. Influenza Avian Flu strain has become more contagious and dangerous.
4. A Vaccine for the impending pandemic Avian Influenza
5. Influenza Vaccination for children with neurological or neuromuscular disease
6. Avian Influenza: Government to set up expert committee
7. Resistant Influenza strains creates panic in US
8. Influenza Vaccination For The Elderly
9. Fao Declares Humans Spread Avian Influenza Virus
10. Statins Could Play Important Role In Influenza Pandemic
11. Zoo Animal Succumbs to Avian Influenza in Germany
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
Breaking Medicine Technology: